LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.84 | 27.76 | 556 | 6965 | 0.0798 | 0.4565 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.84 | 27.76 | 3974 | 6965 | 0.5706 | 0.8641 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.55 | 27.76 | 212 | 6928 | 0.0306 | 0.2908 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.55 | 27.76 | 3624 | 6928 | 0.5230 | 0.8437 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.55 | 27.76 | 501 | 6928 | 0.0723 | 0.4381 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.55 | 27.76 | 4094 | 6928 | 0.5909 | 0.8721 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.25 | 27.76 | 220 | 6873 | 0.0320 | 0.2974 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.25 | 27.76 | 3751 | 6873 | 0.5457 | 0.8533 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.25 | 27.76 | 510 | 6873 | 0.0742 | 0.4420 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.25 | 27.76 | 4169 | 6873 | 0.6066 | 0.8781 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 93.96 | 27.76 | 196 | 6849 | 0.0286 | 0.2788 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 93.96 | 27.76 | 3876 | 6849 | 0.5659 | 0.8617 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 93.96 | 27.76 | 428 | 6849 | 0.0625 | 0.4109 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 93.96 | 27.76 | 4277 | 6849 | 0.6245 | 0.8849 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 95.66 | 27.76 | 192 | 6712 | 0.0286 | 0.2767 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 95.66 | 27.76 | 3992 | 6712 | 0.5947 | 0.8729 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 95.66 | 27.76 | 448 | 6712 | 0.0667 | 0.4209 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 95.66 | 27.76 | 4312 | 6712 | 0.6424 | 0.8913 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 1.95 | 27.76 | 414 | 225 | 1.8388 | 1.4470 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 1.95 | 27.76 | 535 | 225 | 2.3763 | 1.6638 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.66 | 27.76 | 539 | 283 | 1.8984 | 1.4211 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | N12 |